Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents

Magnetic Resonance in Medicine

Volumn 54, Issue 4, 2005, Pages 807-812

  Allen, Mark ^a   Bulte, Jeff W M ^b   Liepold, Lars ^a   Basu, Gautam ^c   Zywicke, Holly A ^d   Frank, Joseph A ^d   Young, Mark ^a   Douglas, Trevor ^a  

^a MONTANA STATE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSE INSTITUTE   (India)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

FRET; Gadolinium; MR contrast agent; Relaxometry; Virus particles

Indexed keywords

BINDING ENERGY; BINDING SITES; DISSOCIATION; ENERGY TRANSFER; FORSTER RESONANCE ENERGY TRANSFER; GADOLINIUM; NANOMAGNETICS; NANOPARTICLES; PARAMAGNETISM; PROTEINS; VIRUSES;

COWPEA CHLOROTIC MOTTLE VIRUS; DISSOCIATION CONSTANT; FLUORESCENCE RESONANCE ENERGY TRANSFER; FRET; MAGNETIC RESONANCE CONTRAST AGENTS; MR CONTRAST AGENTS; RELAXOMETRY; VIRUS PARTICLES;

MAGNETIC RESONANCE;

CALCIUM ION; CONTRAST MEDIUM; GADOLINIUM; NANOPARTICLE; TERBIUM; VIRUS PROTEIN; WATER;

ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; COWPEA CHLOROTIC MOTTLE VIRUS; CRYOELECTRON MICROSCOPY; DISSOCIATION CONSTANT; FLUORESCENCE RESONANCE ENERGY TRANSFER; METAL BINDING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PICHIA PASTORIS; PLANT VIRUS; TRANSMISSION ELECTRON MICROSCOPY; VIRUS PARTICLE;

EID: 26844517318     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20614     Document Type: Article

References (35)

1. Bryant LH, Brechbiel MW, Wu CC, Bulte JWM, Herynek V Frank JA. Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates. J Magn Reson Imaging 1999;9:348-352.
2. Kobayashi H, Sato N, Kawamoto S, Saga T, Hiraga A, Haque TL, Ishimori T, Konishi J, Togashi K Brechbiel MW. Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer. Bioconj Chem 2001;12:100-107.
3. Wiener EC, Brechbiel MW, Brothers H, Magin RL, Gansow OA, Tomalia DA, Lauterbur PC. Dendrimer-based metal-chelates-a new class of magnetic-resonance- imaging contrast agents. Magn Reson Med 1994; 31:1-8.
4. Mikawa M, Kato H, Okumura M, Narazaki M, Kanazawa Y, Miwa N Shinohara H. Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconj Chem 2001;12:510-514.
5. Aime S, Frullano L, Crich SG. Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging. Angew Chem Int Ed 2002;41:1017.
6. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KCP. Detection of tumor angiogenesis in vivo by alpha(v)beta(3)-targeted magnetic resonance imaging. Nat Med 1998;4:623-626.
7. Winter PM, Caruthers SD, Yu X, Song SK, Chen JJ, Miller B, Bulte JWM, Robertson JD, Gaffney PJ, Wickline SA, Lanza GM. Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med 2003;50:411-416.
8. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem Rev 1999;99:2293-2352.
9. Aime S, Botta M, Fasano M Terreno E. Lanthanide(III) chelates for NMR biomedical applications. Chem Soc Rev 1998;27:19-29.
10. Hood JD, Bednarski M, Frausto R, Guccione S, Reisfeld RA, Xiang R Cheresh DA. Tumor regression by targeted gene delivery to the neovasculature. Science 2002;296:2404-2407.
11. Lanza GM, Yu X, Winter PM, Abendschein DR, Karukstis KK, Scott MJ, Chinen LK, Fuhrhop RW, Scherrer DE, Wickline SA. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent implications for rational therapy of restenosis. Circulation 2002;106:2842-2847.
12. Douglas T, Young M. Host-guest encapsulation of materials by assembled virus protein cages. Nature 1998;393:152-155.
13. Raja KS, Wang Q, Gonzalez MJ, Manchester M, Johnson JE, Finn MG. Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus. Biomacromolecules 2003;4:472-476.
14. St George JA. Gene therapy progress and prospects: adenoviral vectors. Gene Ther 2003;10:1135-1141.
15. Gluck R Metcalfe IC. New technology platforms in the development of vaccines for the future. Vaccine 2002;20:B10-B16.
16. Polo JM, Dubensky TW. Virus-based vectors for human vaccine applications. Drug Discov Today 2002;7:719-727.
17. Douglas T, Young M. Virus particles as templates for materials synthesis. Adv Mater 1999;11:679.
18. Douglas T, Strable E, Willits D, Aitouchen A, Libera M, Young M. Protein engineering of a viral cage for constrained nanomaterials synthesis. Adv Mater 2002;14:415.
19. Basu G, Allen M, Willits D, Young M Douglas T. Metal binding to cowpea chlorotic mottle virus using terbium(III) fluorescence. J Biol Inorg Chem 2003;8:721-725.
20. Shenton W, Douglas T, Young M, Stubbs G, Mann S. Inorganic-organic nanotube composites from template mineralization of tobacco mosaic virus. Adv Mater 1999;11:253.
21. Wang Q, Kaltgrad E, Lin TW, Johnson JE, Finn MG. Natural supramolecular building blocks: wild-type cowpea mosaic virus. Chem Biol 2002;9:805-811.
22. Johnson J, Lin T Lomonossoff G. Presentation of heterologous peptides on plant viruses: genetics, structure, and function. Annu Rev Phytopathol 1997;35:67-86.
23. Wang Q, Lin TW, Johnson JE, Finn MG. Natural supramolecular building blocks: cysteine-added mutants of cowpea mosaic virus. Chem Biol 2002;9:813-819.
24. Gillitzer E, Willits D, Young M, Douglas T. Chemical modification of a viral cage for multivalent presentation. Chem Commun 2002;2390-2391.
25. Chatterji A, Burns LL, Taylor SS, Lomonossoff GP, Johnson JE, Lin T, Porta C. Cowpea mosaic virus: from the presentation of antigenic peptides to the display of active biomaterials. Intervirology 2002;45:362-370.
26. Chillon M, Lee JH, Fasbender A Welsh MJ. Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro. Gene Ther 1998;5:995-1002.
27. Dragnea B, Chen C, Kwak ES, Stein B Kao CC. Gold nanoparticles as spectroscopic enhancers for in vitro studies on single viruses. J Am Chem Soc 2003;125:6374-6375.
28. Speir JA, Munshi S, Wang GJ, Baker TS, Johnson JE. Structures of the native and swollen forms of Cowpea chlorotic mottle virus determined by X-ray crystallography and cryoelectron microscopy, structure 1995; 3:63-78.
29. Brumfield S, Willits D, Tang L, Johnson JE, Douglas T Young M. Heterologous expression of the modified coat protein of Cowpea chlorotic mottle bromovirus results in the assembly of protein cages with altered architectures and function. J Gen Virol 2004;85:1049-1053.
30. Vazquez-Ibar JL, Weinglass AB, Kaback HR. Engineering a terbium-binding site into an integral membrane protein for luminescence energy transfer. Proc Natl Acad Sci USA 2002;99:3487-3492.
31. Hvattum E, Normann PT, Jamieson GC, Lai JJ, Skotland T. Detection and quantitation of gadolinium chelates in human serum and urine by high-performance liquid-chromatography and postcolumn derivatization of gadolinium with Arsenazo-III. J Pharm Biomed Anal 1995;13: 927-932.
32. Ye YM, Shealy S, Lee HW, Torshin I, Harrison R Yang JJ. A grafting approach to obtain site-specific metal-binding properties of EF-hand proteins. Protein Eng 2003;16:429-434.
33. Reddy VS, Natarajan P, Okerberg B, Li K, Damodaran KV, Morton RT, Brooks C Johnson JE. Virus Particle Explorer (VIPER), a Website for virus capsid structures and their computational analyses. J Virol 2001; 75:11943-11947.
34. Vymazal J, Bulte JWM, Frank JA, Dichiro G Brooks RA. Frequency-dependence of MR relaxation times. 1. Paramagnetic ions. J Magn Reson Imaging 1993;3:637-640.
35. Caravan P, Cloutier NJ, Greenfield MT, McDermid SA, Dunham SU, Bulte JWM, Amedio JC, Looby RJ, Supkowski RM, Horrocks WD, McMurry TJ, Lauffer RB. The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc 2002;124:3152-3162.